Current press information on migraine and headache research, migraine and headache diagnostics, migraine and headache therapy
Prof. Dr. Hartmut Göbel Migraines and headaches are a widespread disease. They either put a strain on you. Or you at least know a lot of people around you who suffer from headaches. Even small children can often [...]
Prof. Dr. Hartmut Göbel Prof. Dr. med. Hartmut Göbel, head physician at the Kiel Pain Clinic, is one of Germany's top doctors in the field of pain therapy according to the editorial team of Focus Health based on an independent assessment. The [...]
On Friday, February 27, 2020, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) announced on its website that it recommends that the marketing authorization application for Emgality® (galcanezumab) for the prophylaxis of episodic cluster headache in adults [.. .]
Generations of students have struggled with the problem that a word can have a different gender in different languages. The assignment to female, male or objective gender often seems rather arbitrary. A typical [...]
Kiel, April 7, 2019. The first scientific analysis of the therapeutic behavior of migraine and headache patients when receiving digital therapy support with the migraine app was published today in the current print edition of the scientific journal Der Pain. It is about [...]
Kiel, January 16, 2019. The first scientific analysis of the treatment behavior of migraine and headache patients when receiving digital therapy support with the migraine app was published today in the specialist journal Der Pain. This is the first scientific publication on the application [...]
London, 10 January 2019. The National Institute for Health and Care Excellence (NICE) is assessing guidance on health technologies, clinical practice and prevention for the UK Department of Health. The [...]
The diseases headache and migraine not only affect the lives of those affected, but also cause economic damage. Newly developed antibodies intervene specifically in the molecular development process of migraines and can therefore preventively reduce the likelihood [...]
The first week of September is used internationally to educate people about migraines in order to raise awareness of the great importance of the health problem. Prejudices and stigmas should be reduced. Prof. Hartmut Göbel answers current questions about migraines, their effects [...]
Kiel, August 1st, 2018. The Prime Minister of Schleswig-Holstein, Daniel Günther, presented today in the presence of the Minister of Health Dr. Heiner Garg and district president Dr. Juliane Rumpf and numerous guests of honor received the Cross of Merit 1st awarded to her by Federal President Frank-Walter Steinmeier.
July 30, 2018. The migraine immunotherapy with the active ingredient erenumab (Aimovig) can now also be sold in the EU. The US approval was initially given in May 2018, followed by approval in Switzerland in July. Now the [...]
In the FAZ study “Germany's Best Hospitals”, the Kiel Pain Clinic takes the top position nationwide among specialized inpatient pain therapy clinics. Based on all around 2000 hospitals in Germany, it was ranked among the 10 best clinics [...]
Tension-type headaches are the most common headaches. Topical topical treatment with peppermint oil (Oleum menthae piperitae) has been shown to be significantly effective compared to placebo in controlled studies. Peppermint oil has numerous mechanisms of action in the [...]
Headaches are a common problem. 54 million people in Germany are affected. Dr. Heinz-Wilhelm Esser meets headache patients. During his visit to the Kiel Pain Clinic, he found out about, among other things, the causes of migraines and headaches, [...]
In these click tips, Prof. Hartmut Göbel from the Kiel Pain Clinic shows you how the migraine app analyzes the course of treatment individually, supports and optimizes the treatment. In the list below you will find the complete series of all [...]
With the current update of the migraine app from the Kiel Pain Clinic and the Techniker Krankenkasse (TK), many new functions are available. These are intended to help those affected to better classify headache attacks and to distinguish them from other neurological diseases.
Approximately 30% of pregnant women take the painkiller ibuprofen in the first 3 months of pregnancy. Ibuprofen works by inhibiting prostaglandin synthesis. It has long been known that this can affect pregnancy and/or embryo-fetal development [...]
On November 29, 2017, the results of two studies on the effectiveness of antibodies against CGRP in preventing chronic and episodic migraines were published in the New England Journal of Medicine1,2. The antibody therapy targets a molecule [...]
We have great news for you: The app for Android smartphones is available in the Google Play Store. Download via link below. This means you can conduct video consultations quickly and easily using your smartphone. The app for Apple's [...]
Dear reader, The new clinic brochure from the Kiel Pain Clinic has been updated and expanded. It is available for you to download here. The brochure has been supplemented with important innovations, such as information on the treatment process and [...]
